| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2007: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Research Abstract |
The nucleoside analogue FLT with PET has been introduced for imaging cell proliferation. The purpose of this study is to assess the clinical value of F-18 FLT PET in patients who suspected lung tumors on CT scan or chest X-ray, and to compare the uptake of F-18 FLT and F-18 FDG. Our experience demonstrates that F-18 FDG PET shows higher sensitivity than F-18 FLT PET for depiction of lung cancer, however, F-18 FLT PET shows higher specificity than F-18 FDG PET. F-18 FLT PET shows better specificity for lymph node staging than F-18 FDG PET. F-18 FLT PET is not sensitive than F-18 FDG PET for detection of distant metastasis. Follow-up F-18 FLT PET may be helpful for monitoring therapeutic assessment.
|
